Prosecution Insights
Last updated: April 19, 2026
Application No. 17/605,160

SURFACE-TREATED MAGNESIUM OR CALCIUM ION-CONTAINING MATERIALS AS WHITE PIGMENTS IN ORAL CARE COMPOSITIONS

Non-Final OA §102§103§DP
Filed
Oct 20, 2021
Examiner
BAUM, ZACHARY JOHN
Art Unit
1736
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Omya International AG
OA Round
4 (Non-Final)
79%
Grant Probability
Favorable
4-5
OA Rounds
2y 9m
To Grant
93%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
86 granted / 109 resolved
+13.9% vs TC avg
Moderate +14% lift
Without
With
+14.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
26 currently pending
Career history
135
Total Applications
across all art units

Statute-Specific Performance

§103
41.4%
+1.4% vs TC avg
§102
21.0%
-19.0% vs TC avg
§112
28.4%
-11.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 109 resolved cases

Office Action

§102 §103 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments, see Page 9, lines 1-5 of Remarks, filed January 5th, 2026, with respect to the rejection of claims 1, 3, and 16-18 under 35 U.S.C. 103 have been fully considered and are persuasive. Because the allowable subject matter of claims 4/19 has been incorporated into the independent claim 1, the rejection has been withdrawn in consideration of the elected species (phosphoric acid and hydromagnesite) therein. However, upon extending examination to the non-elected species in claim 1, new grounds of rejection are made in view of the prior art. Applicant’s request for rejoinder is currently denied as unripe. Election/Restrictions The Office Action dated October 3rd, 2025 indicated allowable subject matter in dependent claims 4, 6 and 19 as presented on July 15th, 2025 for the elected species “phosphoric acid” and “hydromagnesite (Mg5(CO3)4(OH)2•4H2O)”. In accordance with MPEP 803.02, examination was extended to the non-elected species, and search and examination was continued until prior art was found that anticipates or renders obvious the species in the Markush group of claim 1. In addition to the previously elected species, the magnesium ion-containing materials “anhydrous magnesium carbonate”, “magnesite (MgCO3)”, and “brucite (Mg(OH)2)” were searched, resulting in the prior art rejections below. No additional searching of surface-treating compounds was required to identify the relevant prior art. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 3, and 19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Rothon (U.S. Patent No. 5,461,101, 1995), as further evidenced by Michaux (EP 2169027 A1). Regarding claim 1, Rothon teaches a surface-treated magnesium ion-containing material obtained by treating the surface of a magnesium ion-containing material with a water-insoluble polymer (Rothon, Col. 5, line 40 - Col. 6, line 6 and Col. 7, line 55 - Col. 8, line 22; Table 2, ethylene vinyl acetate (EVA)-treated magnesium hydroxide); wherein the magnesium ion-containing material is brucite (Mg(OH)2) (Rothon, Table 3, magnesium hydroxide; see below); and wherein the magnesium ion-containing material prior to surface treatment is in form of particles having a BET specific surface area of 18 m2/g (Rothon, Col. 6, lines 3-5). Rothon does not explicitly teach that the magnesium hydroxide is brucite (Mg(OH)2). However, Rothon teaches that the magnesium hydroxide is formed by hydration of magnesium oxide (Rothon, Col. 5, lines 48-55). Michaux teaches that magnesium hydroxide formed by hydration of magnesium oxide is in the form of brucite (Mg(OH)2) (Michaux, [0009]). Therefore, despite being silent to the exact form of magnesium hydroxide, Rothon’s magnesium hydroxide would necessarily be brucite (Mg(OH)2). Rothon does not explicitly teach that the BET surface area is measured using nitrogen according to ISO 9277:2010. However, in the absence of evidence to the contrary, it is presumed that the BET method employed by Rothon would produce results consistent with what would be obtained with ISO 9277:2010 using nitrogen. Regarding claim 3, Rothon teaches the surface-treated magnesium ion-containing material according to claim 1, as discussed above, wherein the magnesium ion-containing material prior to surface treatment is in form of particles having a volume median grain diameter of 800 nm (Rothon, Col. 6, lines 3-6). Rothon does not explicitly teach that the d50 value is determined by laser diffraction. However, in the absence of evidence to the contrary, it is presumed that the method of determining d50 employed by Rothon would produce results consistent with what would be obtained via laser diffraction. Regarding claim 19, Rothon teaches the surface-treated magnesium ion-containing material according to claim 1, as discussed above, wherein the magnesium ion-containing material prior to surface treatment is in form of particles having a BET specific surface area of 18 m2/g (Rothon, Col. 6, lines 3-5; see discussion of claim 1 above regarding ISO standard). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1, 3, 6, and 16-19 are rejected under 35 U.S.C. 103 as being unpatentable over Singh (WO 2017/184952 A1). Regarding claim 1, Singh teaches a surface-treated inorganic material (Singh, [0047]) obtained by treating the surface of an inorganic material with a compound selected from a list including hexanoic acid (Singh, [0064]); wherein the inorganic material is selected from a list including anhydrous magnesium carbonate (Singh, [0063], “a carbonate of magnesium” is understood to be anhydrous magnesium carbonate, absent any mention of the magnesium carbonate being hydrated); and the inorganic material prior to surface treatment is in form of particles having a BET specific surface area of 8 to 20 m2/g (Singh, [0029]; Singh, [0064], “According to extended embodiments of the above methods, the dried inorganic particulate material as described above may be treated with a surface treatment agent to further tailor the surface properties of the inorganic particulate material.” (emphasis added)). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the invention to have selected hexanoic acid (a carboxylic acid containing six carbon atoms) as the surface-treating compound and anhydrous magnesium carbonate as the magnesium-ion containing material in Singh. The selection of a known material, which is based upon its suitability for the intended use, is within the ambit of one of ordinary skill in the art. See In re Leshin, 125 USPQ 416 (CCPA 1960), Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945), and MPEP § 2144.07. In the instant case, Singh teaches that these materials are suitable as a surface-treating agent and a material to be treated (Singh, [0064] and [0063], respectively), so they would be obvious to select. Singh does not explicitly teach that the BET surface area is measured using nitrogen according to ISO 9277:2010. However, in the absence of evidence to the contrary, it is presumed that the BET method employed by Singh would produce results consistent with what would be obtained with ISO 9277:2010 using nitrogen. Regarding claims 3 and 16-18, Singh renders the surface-treated magnesium ion-containing material according to claim 1 obvious, wherein the magnesium ion-containing material prior to surface treatment is in form of particles having a volume medium grain diameter (d50) of about 0.5 μm to about 2 μm (Singh, [0061]), and a volume determined top cut particle size (d98) of from about 5 μm to about 20 μm (Singh, [0062]). Singh does not explicitly teach that the d50 and d98 values are determined by laser diffraction. However, in the absence of evidence to the contrary, it is presumed that the method of determining d50 and d98 employed by Singh would produce results consistent with what would be obtained via laser diffraction. Regarding claim 6, Singh renders the surface-treated magnesium ion-containing material according to claim 1 obvious, as discussed above, wherein the surface-treated magnesium ion-containing material is obtained by treating the surface of the magnesium ion-containing material with the compound in an amount from 0.1 to 1.0 wt.-%, based on the total dry weight of the magnesium ion-containing material (Singh, [0065]). Regarding claim 19, Singh renders the surface-treated magnesium ion-containing material according to claim 1 obvious, as discussed above, wherein the magnesium ion-containing material prior to surface treatment is in form of particles having a BET specific surface area in the range from 8 to 20 m2/g (Singh, [0029]). As discussed above for claim 1, it is presumed that the BET specific surface area measurement technique used by Singh would produce results consistent with ISO 9277:2010 with nitrogen. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1, 3, 6, and 16-19 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-5 of copending Application No. 17/605,158 (“’158”, reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because claims 1-5 of ‘158 overlap in scope with instant claims 1, 3, 6, and 16-19. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ZACHARY J. BAUM whose telephone number is (571)270-0895. The examiner can normally be reached Monday-Friday 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anthony Zimmer can be reached at 571-270-3590. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ZACHARY JOHN BAUM/Examiner, Art Unit 1736 /ANTHONY J ZIMMER/Supervisory Patent Examiner, Art Unit 1736
Read full office action

Prosecution Timeline

Oct 20, 2021
Application Filed
Oct 02, 2024
Non-Final Rejection — §102, §103, §DP
Jan 06, 2025
Response Filed
Mar 10, 2025
Final Rejection — §102, §103, §DP
Jul 15, 2025
Request for Continued Examination
Jul 17, 2025
Response after Non-Final Action
Oct 01, 2025
Non-Final Rejection — §102, §103, §DP
Jan 05, 2026
Response Filed
Feb 09, 2026
Non-Final Rejection — §102, §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595183
METHOD FOR PRODUCTION OF SHEET PHASE PSEUDO-BOEHMITE USING COUETTE-TAYLOR VORTEX REACTION
2y 5m to grant Granted Apr 07, 2026
Patent 12595185
PROCESS FOR RECOVERING MATERIALS FROM BAUXITE RESIDUE, MICROWAVE REACTOR FOR HEATING MINING PRODUCTS AND METHOD FOR HEATING A MINING PRODUCT
2y 5m to grant Granted Apr 07, 2026
Patent 12592383
Method of Manufacturing Cathode Active Material for Lithium Secondary Battery
2y 5m to grant Granted Mar 31, 2026
Patent 12590353
PROCESS FOR THE RECOVERY OF HIGH PURITY Metallic SODIUM AND THE SAFE TREATMENT OF HIGH CALCIUM CONTENT SODIUM SLAG
2y 5m to grant Granted Mar 31, 2026
Patent 12584190
Methods for Selective Recovery of Rare Earth Elements and Metals from Coal Ash by Ionic Liquids
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

4-5
Expected OA Rounds
79%
Grant Probability
93%
With Interview (+14.0%)
2y 9m
Median Time to Grant
High
PTA Risk
Based on 109 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month